Global Artificial Organ & Bionics 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR062411931

Publication Date:

June 21, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Artificial Organ & Bionics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Artificial organs and bionics are advanced medical devices or systems designed to replace or enhance the functionality of specific organs or body parts. These technologies aim to improve the quality of life for individuals with organ failure or physical disabilities.
The market for artificial organs and bionics is driven by the increasing incidence of organ failure, chronic diseases, and physical disabilities. Advancements in bioengineering, materials science, and prosthetics have led to the development of more sophisticated and functional artificial organs, boosting the market's growth.
This report includes an overview of the development of the Artificial Organ & Bionics industry chain, the market status of Hospital (Mechanical Bionics, Electronic Bionics), Clinic (Mechanical Bionics, Electronic Bionics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Artificial Organ & Bionics.
Regionally, the report analyzes the Artificial Organ & Bionics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Artificial Organ & Bionics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Artificial Organ & Bionics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Artificial Organ & Bionics industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Mechanical Bionics, Electronic Bionics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Artificial Organ & Bionics market.
Regional Analysis: The report involves examining the Artificial Organ & Bionics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Artificial Organ & Bionics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Artificial Organ & Bionics:
Company Analysis: Report covers individual Artificial Organ & Bionics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Artificial Organ & Bionics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Artificial Organ & Bionics. It assesses the current state, advancements, and potential future developments in Artificial Organ & Bionics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Artificial Organ & Bionics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Artificial Organ & Bionics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Mechanical Bionics
Electronic Bionics
麻豆原创 segment by Application
Hospital
Clinic
Others
麻豆原创 segment by players, this report covers
Abiomed
Asahi Kasei Kuraray Medical
Thoratec
WorldHeart
Gambro AB
Guanhao Biotech
Venus Medtech
Weigao Medical Polymer
Zhenghai Bio-Tech
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Organ & Bionics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Organ & Bionics, with revenue, gross margin and global market share of Artificial Organ & Bionics from 2019 to 2024.
Chapter 3, the Artificial Organ & Bionics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Artificial Organ & Bionics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Organ & Bionics.
Chapter 13, to describe Artificial Organ & Bionics research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Artificial Organ & Bionics
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Artificial Organ & Bionics by Type
1.3.1 Overview: Global Artificial Organ & Bionics 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Artificial Organ & Bionics Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Mechanical Bionics
1.3.4 Electronic Bionics
1.4 Global Artificial Organ & Bionics 麻豆原创 by Application
1.4.1 Overview: Global Artificial Organ & Bionics 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Artificial Organ & Bionics 麻豆原创 Size & Forecast
1.6 Global Artificial Organ & Bionics 麻豆原创 Size and Forecast by Region
1.6.1 Global Artificial Organ & Bionics 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Artificial Organ & Bionics 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Artificial Organ & Bionics 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Artificial Organ & Bionics 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Artificial Organ & Bionics 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Artificial Organ & Bionics 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Artificial Organ & Bionics 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Abiomed
2.1.1 Abiomed Details
2.1.2 Abiomed Major Business
2.1.3 Abiomed Artificial Organ & Bionics Product and Solutions
2.1.4 Abiomed Artificial Organ & Bionics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Abiomed Recent Developments and Future Plans
2.2 Asahi Kasei Kuraray Medical
2.2.1 Asahi Kasei Kuraray Medical Details
2.2.2 Asahi Kasei Kuraray Medical Major Business
2.2.3 Asahi Kasei Kuraray Medical Artificial Organ & Bionics Product and Solutions
2.2.4 Asahi Kasei Kuraray Medical Artificial Organ & Bionics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Asahi Kasei Kuraray Medical Recent Developments and Future Plans
2.3 Thoratec
2.3.1 Thoratec Details
2.3.2 Thoratec Major Business
2.3.3 Thoratec Artificial Organ & Bionics Product and Solutions
2.3.4 Thoratec Artificial Organ & Bionics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Thoratec Recent Developments and Future Plans
2.4 WorldHeart
2.4.1 WorldHeart Details
2.4.2 WorldHeart Major Business
2.4.3 WorldHeart Artificial Organ & Bionics Product and Solutions
2.4.4 WorldHeart Artificial Organ & Bionics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 WorldHeart Recent Developments and Future Plans
2.5 Gambro AB
2.5.1 Gambro AB Details
2.5.2 Gambro AB Major Business
2.5.3 Gambro AB Artificial Organ & Bionics Product and Solutions
2.5.4 Gambro AB Artificial Organ & Bionics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Gambro AB Recent Developments and Future Plans
2.6 Guanhao Biotech
2.6.1 Guanhao Biotech Details
2.6.2 Guanhao Biotech Major Business
2.6.3 Guanhao Biotech Artificial Organ & Bionics Product and Solutions
2.6.4 Guanhao Biotech Artificial Organ & Bionics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Guanhao Biotech Recent Developments and Future Plans
2.7 Venus Medtech
2.7.1 Venus Medtech Details
2.7.2 Venus Medtech Major Business
2.7.3 Venus Medtech Artificial Organ & Bionics Product and Solutions
2.7.4 Venus Medtech Artificial Organ & Bionics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Venus Medtech Recent Developments and Future Plans
2.8 Weigao Medical Polymer
2.8.1 Weigao Medical Polymer Details
2.8.2 Weigao Medical Polymer Major Business
2.8.3 Weigao Medical Polymer Artificial Organ & Bionics Product and Solutions
2.8.4 Weigao Medical Polymer Artificial Organ & Bionics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Weigao Medical Polymer Recent Developments and Future Plans
2.9 Zhenghai Bio-Tech
2.9.1 Zhenghai Bio-Tech Details
2.9.2 Zhenghai Bio-Tech Major Business
2.9.3 Zhenghai Bio-Tech Artificial Organ & Bionics Product and Solutions
2.9.4 Zhenghai Bio-Tech Artificial Organ & Bionics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Zhenghai Bio-Tech Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Artificial Organ & Bionics Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Artificial Organ & Bionics by Company Revenue
3.2.2 Top 3 Artificial Organ & Bionics Players 麻豆原创 Share in 2023
3.2.3 Top 6 Artificial Organ & Bionics Players 麻豆原创 Share in 2023
3.3 Artificial Organ & Bionics 麻豆原创: Overall Company Footprint Analysis
3.3.1 Artificial Organ & Bionics 麻豆原创: Region Footprint
3.3.2 Artificial Organ & Bionics 麻豆原创: Company Product Type Footprint
3.3.3 Artificial Organ & Bionics 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Artificial Organ & Bionics Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Artificial Organ & Bionics 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Artificial Organ & Bionics Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Artificial Organ & Bionics 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Artificial Organ & Bionics Consumption Value by Type (2019-2030)
6.2 North America Artificial Organ & Bionics Consumption Value by Application (2019-2030)
6.3 North America Artificial Organ & Bionics 麻豆原创 Size by Country
6.3.1 North America Artificial Organ & Bionics Consumption Value by Country (2019-2030)
6.3.2 United States Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Artificial Organ & Bionics Consumption Value by Type (2019-2030)
7.2 Europe Artificial Organ & Bionics Consumption Value by Application (2019-2030)
7.3 Europe Artificial Organ & Bionics 麻豆原创 Size by Country
7.3.1 Europe Artificial Organ & Bionics Consumption Value by Country (2019-2030)
7.3.2 Germany Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Artificial Organ & Bionics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Artificial Organ & Bionics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Artificial Organ & Bionics 麻豆原创 Size by Region
8.3.1 Asia-Pacific Artificial Organ & Bionics Consumption Value by Region (2019-2030)
8.3.2 China Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Artificial Organ & Bionics Consumption Value by Type (2019-2030)
9.2 South America Artificial Organ & Bionics Consumption Value by Application (2019-2030)
9.3 South America Artificial Organ & Bionics 麻豆原创 Size by Country
9.3.1 South America Artificial Organ & Bionics Consumption Value by Country (2019-2030)
9.3.2 Brazil Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Artificial Organ & Bionics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Artificial Organ & Bionics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Artificial Organ & Bionics 麻豆原创 Size by Country
10.3.1 Middle East & Africa Artificial Organ & Bionics Consumption Value by Country (2019-2030)
10.3.2 Turkey Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Artificial Organ & Bionics 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Artificial Organ & Bionics 麻豆原创 Drivers
11.2 Artificial Organ & Bionics 麻豆原创 Restraints
11.3 Artificial Organ & Bionics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Artificial Organ & Bionics Industry Chain
12.2 Artificial Organ & Bionics Upstream Analysis
12.3 Artificial Organ & Bionics Midstream Analysis
12.4 Artificial Organ & Bionics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Abiomed
Asahi Kasei Kuraray Medical
Thoratec
WorldHeart
Gambro AB
Guanhao Biotech
Venus Medtech
Weigao Medical Polymer
Zhenghai Bio-Tech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.